Our experimental results showed that arsenic significantly increased the levels of hepatonephric IL-1β, IL-6, Il-12, and TNF-α in both 1 and 3 months, suggesting that subchronic arsenic exposure could lead to hepatorenal persistent inflammatory response, which may be further meaningful to raise the incidences of liver and kidney cancers. Here, IL1B is linked to kidney cancer.